Latest News and Press Releases

-Single Agent Solid Tumor Clinical Benefit Seen With Tumor Metabolism Inhibitor CB-839 -Continued Signs of Activity, Tolerability, and Durability -First Preclinical Data Presented For...

CHARLOTTE, N.C., Nov. 09, 2015 (GLOBE NEWSWIRE) -- Premier, Inc. (NASDAQ:PINC) today reported financial results for the fiscal 2016 first quarter ended September 30, 2015.      ...

Generated Cash Available for Distribution (“CAFD”) of $71 million, up 9% over previous quarterIncreases 3Q dividend to $0.35 per share ($1.40 annualized), up 4% over previous quarterSolid...

Initiated Rolling BLA submission to FDA for Andexanet alfa --Conference Call Today at 4:30 p.m. ET-- SOUTH SAN FRANCISCO, Calif., Nov. 09, 2015 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals...

PALO ALTO, Calif. and RESEARCH TRIANGLE PARK, N.C., Nov. 09, 2015 (GLOBE NEWSWIRE) -- Ocera Therapeutics, Inc. (NASDAQ:OCRX), a clinical stage biopharmaceutical company focused on acute and...

Free cash of $8.7 million reflects continuing emphasis on working capital improvements (free cash defined as cash flow from operations less capital expenditures)Quarterly dividend declared of $0.50...

ENGLEWOOD, Colo., Nov. 09, 2015 (GLOBE NEWSWIRE) -- Ascent Capital Group, Inc. (“Ascent” or the “Company”) (Nasdaq:ASCMA) has reported results for the three and nine months ended September 30,...

Lump Sum Award in Saudi Arabia and Two New Awards in Qatar Significant Build of Backlog PB Litoral Sail-Away and Float-over Company to Host Conference Call and Webcast Today at 4:00 pm CDT ...

NOVATO, Calif., Nov. 09, 2015 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare...

- Company records $67.3 million in total net product sales - CAMBRIDGE, Mass., Nov. 09, 2015 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR), a biopharmaceutical company...